Abstract
Despite its 100% lethality and the circa 59,000 human deaths every year, rabies is still in want of an effective treatment. A host of trials is described aiming at impairing the life cycle of Lyssavirus rabies (RABV), the chief worldwide lyssavirus causing rabies, but with limited success. Treatments targeting host factors and to circumvent the lesions caused by RABV have also shown unsat…